Case report of abiotrophia defectiva endophthalmitis after repeated injections of dexamethasone intravitreal implant (ozurdex)

Conclusion: Intravitreal dexamethasone implant–associated endophthalmitis in the setting of systemic immunosuppression is a rare and challenging situation. Both local and systemic immunosuppression may delay wound healing, predisposing to wound leakage and consequent endophthalmitis. Despite repeated intravitreal antimicrobial injection and vitrectomy with implant removal, A. defectiva endophthalmitis carried a poor visual outcome.
Source: Retinal Cases and Brief Reports - Category: Opthalmology Tags: Case Report Source Type: research